Insider Stock Trading History of Geraghty James A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Geraghty James A since year 2005. The trader's CIK number is 1239746. At the time of this reporting, Geraghty James A is the Director of Pieris Pharmaceuticals, Inc. . (stock ticker symbol PIRS). See this page for all insider trading activities at Pieris Pharmaceuticals, Inc. .

Note that in the past GERAGHTY JAMES A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Geraghty James A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-17 PIRS Pieris Pharmaceuticals, Inc. Buy 10,000 4.82 48,200
2017-03-17 JNP Columbia Laboratories Inc Buy 2,000 4.82 9,638
2016-09-13 JNP Columbia Laboratories Inc Buy 2,000 5.96 11,930
2016-08-23 JNP Columbia Laboratories Inc Buy 2,937 6.03 17,715
2016-08-22 JNP Columbia Laboratories Inc Buy 4,063 5.90 23,971
2015-11-17 JNP Columbia Laboratories Inc Buy 8,000 11.75 94,000
2015-08-06 JNP Columbia Laboratories Inc Buy 12,000 10.46 125,520
2015-06-01 JNP Columbia Laboratories Inc Buy 20,550 8.38 172,209
2014-05-27 IDRA Hybridon Inc Buy 10,000 2.65 26,500
2013-12-06 IDRA Hybridon Inc Buy 40,000 2.72 108,800
2013-09-16 IDRA Hybridon Inc Buy 60,000 1.90 114,000
2013-08-19 IDRA Hybridon Inc Buy 300,000 1.75 525,000
2011-04-04 GENZ Genzyme Corp Option Ex 9,750 .00 0
2010-06-11 GENZ Genzyme Corp Sale 1,000 48.81 48,810
2010-05-25 GENZ Genzyme Corp Sale 2,329 45.59 106,179
2010-05-24 GENZ Genzyme Corp Option Ex 5,000 .00 0
2009-11-06 GENZ Genzyme Corp Sale 36,875 52.07 1,920,081
2009-11-06 GENZ Genzyme Corp Option Ex 36,875 32.52 1,199,175
2007-12-14 GTCB Gtc Biotherapeutics Inc Buy 10,000 .87 8,690
2006-09-29 GTCB Gtc Biotherapeutics Inc Buy 2,621 1.24 3,250
2005-11-11 GTCB Gtc Biotherapeutics Inc Buy 3,000 1.61 4,824
2005-05-16 GTCB Gtc Biotherapeutics Inc Buy 3,000 1.32 3,960
2005-03-14 GTCB Gtc Biotherapeutics Inc Buy 5,000 1.75 8,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Geraghty James A (Director of Pieris Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.